Comparative efficacy of mepolizumab and benralizumab in severe eosinophilic asthma: a retrospective cohort study. [PDF]
Huang WC +6 more
europepmc +1 more source
Lymphocyte variant hypereosinophilic syndrome with severe eosinophilic pneumonia treated with mepolizumab: a case report. [PDF]
Wang Y, Tao Y, Mao H.
europepmc +1 more source
Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis. [PDF]
Mukherjee M +18 more
europepmc +1 more source
The Impact of BMI on the Effect of Biologic Agents for Severe Asthma. [PDF]
Papadopoulou S +4 more
europepmc +1 more source
Real-world sinonasal outcomes in patients with primary diffuse chronic rhinosinusitis treated with mepolizumab across polyp phenotypes. [PDF]
Kumar N, Patel E, Marino MJ, Lal D.
europepmc +1 more source
Fulminant eosinophilic myocarditis treated by venoarterial extracorporeal membrane oxygenation and adjunctive immunosuppressive therapy: a case report. [PDF]
Suh DW, Lee SH, Lee CJ, Park KH.
europepmc +1 more source
Six-Month Benralizumab Maintenance for Relapsing Chronic Eosinophilic Pneumonia Guided by Eosinophil Kinetics. [PDF]
Sumi T +6 more
europepmc +1 more source
Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial. [PDF]
Gupta A +8 more
europepmc +1 more source
Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR). [PDF]
Alobid I +30 more
europepmc +1 more source

